• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,649.84 382.50
( 0.52%)
Global Indices
Nasdaq
51,095.09 41.63
(0.08%)
Dow Jones
7,620.62 19.56
(0.26%)
Hang Seng
66,649.95 -284.38
(-0.42%)
Nikkei 225
10,313.41 -95.87
(-0.92%)
Forex
USD-INR
94.75 -1.18
(-1.23%)
EUR-INR
110.47 -1.07
(-0.96%)
GBP-INR
127.45 -1.26
(-0.98%)
JPY-INR
0.59 -0.01
(-1.17%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2961161
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
36.97
37331.16
EPS(TTM)
Face Value()
Div & Yield %
59.61
10
2.59
 

emerald finance ltd
PVV Infra consolidated net profit declines 84.91% in the March 2026 quarter
May 30,2026
Net profit of PVV Infra declined 84.91% to Rs 0.08 crore in the quarter ended March 2026 as against Rs 0.53 crore during the previous quarter ended March 2025. Sales rose 223.95% to Rs 21.64 crore in the quarter ended March 2026 as against Rs 6.68 crore during the previous quarter ended March 2025.

For the full year,net profit rose 30.47% to Rs 7.15 crore in the year ended March 2026 as against Rs 5.48 crore during the previous year ended March 2025. Sales rose 42.16% to Rs 56.65 crore in the year ended March 2026 as against Rs 39.85 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales21.646.68 224 56.6539.85 42
OPM %0.46-10.78 -14.8612.82 -
PBDT0.100.62 -84 8.416.45 30
PBT0.100.62 -84 8.416.45 30
NP0.080.53 -85 7.155.48 30